ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pentavalent Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-33B14423
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Pentavalent Vaccine Market Research Report 2023
BUY CHAPTERS

Global Pentavalent Vaccine Market Research Report 2025

Code: QYRE-Auto-33B14423
Report
May 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Serum Institute of India
Biological E Ltd
Novartis
Crucell
Bio-Farma
Panacea Drugs Pvt. Ltd
Shantha Biotechnics

Pentavalent Vaccine Market

The global market for Pentavalent Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
North American market for Pentavalent Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pentavalent Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pentavalent Vaccine include Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., Novartis AG, Crucell, Bio Farma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pentavalent Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pentavalent Vaccine.
The Pentavalent Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pentavalent Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pentavalent Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pentavalent Vaccine Market Report

Report Metric Details
Report Name Pentavalent Vaccine Market
Segment by Type
  • Lyophilized
  • Liquid
Segment by Application
  • Retail Pharmacy
  • Hospital Pharmacy
  • E-commerce
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., Novartis AG, Crucell, Bio Farma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pentavalent Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pentavalent Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Pentavalent Vaccine Market report?

Ans: The main players in the Pentavalent Vaccine Market are Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., Novartis AG, Crucell, Bio Farma

What are the Application segmentation covered in the Pentavalent Vaccine Market report?

Ans: The Applications covered in the Pentavalent Vaccine Market report are Retail Pharmacy, Hospital Pharmacy, E-commerce

What are the Type segmentation covered in the Pentavalent Vaccine Market report?

Ans: The Types covered in the Pentavalent Vaccine Market report are Lyophilized, Liquid

1 Pentavalent Vaccine Market Overview
1.1 Product Definition
1.2 Pentavalent Vaccine by Type
1.2.1 Global Pentavalent Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lyophilized
1.2.3 Liquid
1.3 Pentavalent Vaccine by Application
1.3.1 Global Pentavalent Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 E-commerce
1.4 Global Pentavalent Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pentavalent Vaccine Revenue 2020-2031
1.4.2 Global Pentavalent Vaccine Sales 2020-2031
1.4.3 Global Pentavalent Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pentavalent Vaccine Market Competition by Manufacturers
2.1 Global Pentavalent Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pentavalent Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pentavalent Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pentavalent Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pentavalent Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pentavalent Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Pentavalent Vaccine, Date of Enter into This Industry
2.8 Global Pentavalent Vaccine Market Competitive Situation and Trends
2.8.1 Global Pentavalent Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pentavalent Vaccine Players Market Share by Revenue
2.8.3 Global Pentavalent Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pentavalent Vaccine Market Scenario by Region
3.1 Global Pentavalent Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pentavalent Vaccine Sales by Region: 2020-2031
3.2.1 Global Pentavalent Vaccine Sales by Region: 2020-2025
3.2.2 Global Pentavalent Vaccine Sales by Region: 2026-2031
3.3 Global Pentavalent Vaccine Revenue by Region: 2020-2031
3.3.1 Global Pentavalent Vaccine Revenue by Region: 2020-2025
3.3.2 Global Pentavalent Vaccine Revenue by Region: 2026-2031
3.4 North America Pentavalent Vaccine Market Facts & Figures by Country
3.4.1 North America Pentavalent Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pentavalent Vaccine Sales by Country (2020-2031)
3.4.3 North America Pentavalent Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pentavalent Vaccine Market Facts & Figures by Country
3.5.1 Europe Pentavalent Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pentavalent Vaccine Sales by Country (2020-2031)
3.5.3 Europe Pentavalent Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pentavalent Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pentavalent Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pentavalent Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Pentavalent Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pentavalent Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pentavalent Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pentavalent Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Pentavalent Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pentavalent Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pentavalent Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pentavalent Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pentavalent Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pentavalent Vaccine Sales by Type (2020-2031)
4.1.1 Global Pentavalent Vaccine Sales by Type (2020-2025)
4.1.2 Global Pentavalent Vaccine Sales by Type (2026-2031)
4.1.3 Global Pentavalent Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Pentavalent Vaccine Revenue by Type (2020-2031)
4.2.1 Global Pentavalent Vaccine Revenue by Type (2020-2025)
4.2.2 Global Pentavalent Vaccine Revenue by Type (2026-2031)
4.2.3 Global Pentavalent Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Pentavalent Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pentavalent Vaccine Sales by Application (2020-2031)
5.1.1 Global Pentavalent Vaccine Sales by Application (2020-2025)
5.1.2 Global Pentavalent Vaccine Sales by Application (2026-2031)
5.1.3 Global Pentavalent Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Pentavalent Vaccine Revenue by Application (2020-2031)
5.2.1 Global Pentavalent Vaccine Revenue by Application (2020-2025)
5.2.2 Global Pentavalent Vaccine Revenue by Application (2026-2031)
5.2.3 Global Pentavalent Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Pentavalent Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Serum Institute of India
6.1.1 Serum Institute of India Company Information
6.1.2 Serum Institute of India Description and Business Overview
6.1.3 Serum Institute of India Pentavalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Serum Institute of India Pentavalent Vaccine Product Portfolio
6.1.5 Serum Institute of India Recent Developments/Updates
6.2 Panacea Drugs Pvt. Ltd
6.2.1 Panacea Drugs Pvt. Ltd Company Information
6.2.2 Panacea Drugs Pvt. Ltd Description and Business Overview
6.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product Portfolio
6.2.5 Panacea Drugs Pvt. Ltd Recent Developments/Updates
6.3 Shantha Biotechnics
6.3.1 Shantha Biotechnics Company Information
6.3.2 Shantha Biotechnics Description and Business Overview
6.3.3 Shantha Biotechnics Pentavalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shantha Biotechnics Pentavalent Vaccine Product Portfolio
6.3.5 Shantha Biotechnics Recent Developments/Updates
6.4 Biological E. Ltd.
6.4.1 Biological E. Ltd. Company Information
6.4.2 Biological E. Ltd. Description and Business Overview
6.4.3 Biological E. Ltd. Pentavalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biological E. Ltd. Pentavalent Vaccine Product Portfolio
6.4.5 Biological E. Ltd. Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Company Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Pentavalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis AG Pentavalent Vaccine Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Crucell
6.6.1 Crucell Company Information
6.6.2 Crucell Description and Business Overview
6.6.3 Crucell Pentavalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Crucell Pentavalent Vaccine Product Portfolio
6.6.5 Crucell Recent Developments/Updates
6.7 Bio Farma
6.7.1 Bio Farma Company Information
6.7.2 Bio Farma Description and Business Overview
6.7.3 Bio Farma Pentavalent Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio Farma Pentavalent Vaccine Product Portfolio
6.7.5 Bio Farma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pentavalent Vaccine Industry Chain Analysis
7.2 Pentavalent Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pentavalent Vaccine Production Mode & Process Analysis
7.4 Pentavalent Vaccine Sales and Marketing
7.4.1 Pentavalent Vaccine Sales Channels
7.4.2 Pentavalent Vaccine Distributors
7.5 Pentavalent Vaccine Customer Analysis
8 Pentavalent Vaccine Market Dynamics
8.1 Pentavalent Vaccine Industry Trends
8.2 Pentavalent Vaccine Market Drivers
8.3 Pentavalent Vaccine Market Challenges
8.4 Pentavalent Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Serum Institute of India
Biological E Ltd
Novartis
Crucell
Bio-Farma
Panacea Drugs Pvt. Ltd
Shantha Biotechnics
List of Tables
 Table 1. Global Pentavalent Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pentavalent Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pentavalent Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pentavalent Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pentavalent Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pentavalent Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pentavalent Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pentavalent Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pentavalent Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pentavalent Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pentavalent Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Pentavalent Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pentavalent Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pentavalent Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pentavalent Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pentavalent Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pentavalent Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Pentavalent Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pentavalent Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Pentavalent Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pentavalent Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Pentavalent Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pentavalent Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Pentavalent Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pentavalent Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pentavalent Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pentavalent Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pentavalent Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pentavalent Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pentavalent Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pentavalent Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pentavalent Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pentavalent Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pentavalent Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pentavalent Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pentavalent Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pentavalent Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pentavalent Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pentavalent Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pentavalent Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pentavalent Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pentavalent Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pentavalent Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pentavalent Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pentavalent Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pentavalent Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pentavalent Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pentavalent Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pentavalent Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Pentavalent Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Pentavalent Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Pentavalent Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Pentavalent Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pentavalent Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pentavalent Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Pentavalent Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Pentavalent Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pentavalent Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pentavalent Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Pentavalent Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Pentavalent Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Pentavalent Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Pentavalent Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pentavalent Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pentavalent Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Pentavalent Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Pentavalent Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pentavalent Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Serum Institute of India Company Information
 Table 71. Serum Institute of India Description and Business Overview
 Table 72. Serum Institute of India Pentavalent Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Serum Institute of India Pentavalent Vaccine Product
 Table 74. Serum Institute of India Recent Developments/Updates
 Table 75. Panacea Drugs Pvt. Ltd Company Information
 Table 76. Panacea Drugs Pvt. Ltd Description and Business Overview
 Table 77. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product
 Table 79. Panacea Drugs Pvt. Ltd Recent Developments/Updates
 Table 80. Shantha Biotechnics Company Information
 Table 81. Shantha Biotechnics Description and Business Overview
 Table 82. Shantha Biotechnics Pentavalent Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Shantha Biotechnics Pentavalent Vaccine Product
 Table 84. Shantha Biotechnics Recent Developments/Updates
 Table 85. Biological E. Ltd. Company Information
 Table 86. Biological E. Ltd. Description and Business Overview
 Table 87. Biological E. Ltd. Pentavalent Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Biological E. Ltd. Pentavalent Vaccine Product
 Table 89. Biological E. Ltd. Recent Developments/Updates
 Table 90. Novartis AG Company Information
 Table 91. Novartis AG Description and Business Overview
 Table 92. Novartis AG Pentavalent Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Novartis AG Pentavalent Vaccine Product
 Table 94. Novartis AG Recent Developments/Updates
 Table 95. Crucell Company Information
 Table 96. Crucell Description and Business Overview
 Table 97. Crucell Pentavalent Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Crucell Pentavalent Vaccine Product
 Table 99. Crucell Recent Developments/Updates
 Table 100. Bio Farma Company Information
 Table 101. Bio Farma Description and Business Overview
 Table 102. Bio Farma Pentavalent Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bio Farma Pentavalent Vaccine Product
 Table 104. Bio Farma Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Pentavalent Vaccine Distributors List
 Table 108. Pentavalent Vaccine Customers List
 Table 109. Pentavalent Vaccine Market Trends
 Table 110. Pentavalent Vaccine Market Drivers
 Table 111. Pentavalent Vaccine Market Challenges
 Table 112. Pentavalent Vaccine Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pentavalent Vaccine
 Figure 2. Global Pentavalent Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pentavalent Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Lyophilized Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Global Pentavalent Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pentavalent Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Retail Pharmacy
 Figure 9. Hospital Pharmacy
 Figure 10. E-commerce
 Figure 11. Global Pentavalent Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Pentavalent Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Pentavalent Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global Pentavalent Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Pentavalent Vaccine Report Years Considered
 Figure 16. Pentavalent Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Pentavalent Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Pentavalent Vaccine Players: Market Share by Revenue in Pentavalent Vaccine in 2024
 Figure 19. Pentavalent Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Pentavalent Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Pentavalent Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Pentavalent Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Pentavalent Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Pentavalent Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Pentavalent Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Pentavalent Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Pentavalent Vaccine Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Pentavalent Vaccine Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Pentavalent Vaccine Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Pentavalent Vaccine Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Pentavalent Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Pentavalent Vaccine by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Pentavalent Vaccine by Type (2020-2031)
 Figure 53. Global Pentavalent Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Pentavalent Vaccine by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Pentavalent Vaccine by Application (2020-2031)
 Figure 56. Global Pentavalent Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 57. Pentavalent Vaccine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Fully Liquid Pentavalent Vaccine Market Research Report 2024
Global Combination Vaccines for Children Market Research Report 2024
Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025
Global Combined Polio Vaccine Market Research Report 2024
Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Research Report 2024
Global Trivalent Split Influenza Vaccine Market Research Report 2025
Global DTaP and Tdap Vaccines Market Insights Forecast to 2030
Global Pertussis Vaccination Market Research Report 2025
Global Multivalent Oral Rotavirus Vaccine Market Research Report 2024
Global DPT Vaccines Market Research Report 2025
Global DPT Vaccination Market Research Report 2025
Global Pertussis Vaccine Market Insights Forecast to 2030
Global Diphtheria Tetanus and Pertussis DTaP Vaccine Market Research Report 2024
Pneumococcal Vaccine Polyvalent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pediatric Preventable Vaccine Market Research Report 2024
Global Influenza Vaccine Split Virion Inactivated Quadrivalent Market Research Report 2024
Global Polyvalent Streptococcus Pneumococcal Vaccines Market Research Report 2025
HPV Quadrivalent Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Multivalent Vaccines Market Research Report 2025
Global Whooping Cough Preventable Vaccine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions